Restricted accessResearch articleFirst published online 2007-6
A Randomized,Double-Blind,Vehicle-Controlled,Right/Left Comparative Study of the Efficacy of Acitretin with and without the Co-Administration of 0.1% Tacrolimus Topical Ointment in the Treatment of Moderate to Severe Psoriasis
Topical tacrolimus is effective as monotherapy for inverse psoriasis. Its use in combination with other systemic agents may be an effective treatment for psoriasis in less sensitive areas.
Objective
To determine if topical tacrolimus in combination with oral acitretin is more effective than oral acitretin and vehicle ointment.
Methods
All patients received oral acitretin; subjects were randomized to apply topical tacrolimus to one side of their body and vehicle to the other.
Results
Topical tacrolimus was more effective than vehicle ointment as early as week 4. There were no serious adverse events thought to be due to drug or dose changes during the study.
Limitations
Due to the short time horizon of the study, it may not be appropriate to generalize the results to longer treatment periods.
Conclusions
Topical tacrolimus is an effective psoriasis treatment and was well-tolerated when combined with systemic acitretin in the treatment of psoriasis.
Get full access to this article
View all access options for this article.
References
1.
Astellas Pharma US, Inc.Protopic (Tacrolimus) package insert.2005. Grand Island, N.Y.
2.
Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group. Arch Dermatol.1996 Apr; 132(4): 419–23.
3.
ZonneveldI.M., RubinsA., JablonskaS., DobozyA., RuzickaT., KindP., DubertretL., BosJ.D.Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. Arch Dermatol.1998 Sep; 134(9): 1101–2.
4.
LebwohlM., FreemanA.K., ChapmanM.S., FeldmanS.R., HartleJ.E., HenningA; Tacrolimus Ointment Study Group. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol.2004 Nov; 51(5): 723–30.
SauratJ.H.Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol.1999; 41(3): S2–6.
7.
OlsenE.A., WeedW.W., MeyerC.J., and CoboL.M.A double-blind, placebo controlled trial of acitretin for the treatment of psoriasis. J Am Acad Dermatol.1989; 21(suppl 4, pt 1) 655–662.
8.
LebwohlM., DrakeL., MenterA., KooJ., GottliebA.B., ZanolliM., YoungM., McClellandP.Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol.2001 Oct; 45(4): 544–53.
9.
RuzickaT., SommerburgC., Braun-FalcoO., KosterW., LengenW., LensingW., LetzelH., MeigelW.N., PaulE., PrzybillaB.Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis. Arch Dermatol.1990 Apr; 126(4): 482–6.
10.
LoweN.J., PrystowskyJ.H., BourgetT., EdelsteinJ., NychayS., ArmstrongR.Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol.1991 Apr; 24(4): 591–4.
11.
lestJ., BoerJ.Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone. Br J Dermatol.1989 May; 120(5): 665–70.
12.
SauratJ.H., GeigerJ.M., AmblardP., BeaniJ.C., BoulangerA., ClaudyA., FrenkE., GuilhouJ.J., GrosshansE., MerotY.Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica.1988; 177(4): 218–24.
13.
TanewA., GuggenbichlerA., HonigsmannH., GeigerJ.M., FritschP.Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol.1991 Oct; 25(4): 682–4.
RosenbaumM.M., RoenigkHHJr.Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate. J Am Acad Dermatol.1984 Feb; 10(2 Pt2): 357–61.
16.
VanderveenE.E., EllisC.N., CampbellJ.P., CaseP.C., VoorheesJ.J.Methotrexate and etretinate as concurrent therapies in severe psoriasis. Arch Dermatol.1982 Sep; 118(9): 660–2.
17.
KooJ.Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol.1999 Sep; 41(3 Pt 2): S25–8.
18.
HuJ., BalkrishnanR., CamachoF., LangW., PearceD.J., FleischerA.B.Jr., FeldmanS.R.The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis. J Cutan Med Surg.2004 Nov-Dec; 8(6): 411–4.
19.
LebwohlM., MenterA., KooJ., FeldmanS.R.Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol.2004 Mar; 50(3): 416–30.
20.
GottliebA.B., MillerB., LoweN., ShapiroW., HudsonC., BrightR., LingM., MageeA., McCallC.O., RistT., DummerW., WalickeP., BauerR.J., WhiteM., GarovoyM.Subcutaneously administered efalizumab (anti-CD11a) improves signs and symptoms of moderate to severe plaque psoriasis. J Cutan Med Surg.2003 May-Jun; 7(3): 198–207.
21.
LebwohlM., AstE., CallenJ.P., CullenS.I., HongS.R., Kulp-ShortenC.L., LoweN.J., PhillipsT.J., RosenT., WolfDl, QuellJ.M., SeftonJ., LueJ.C., GibsonJ.R., ChandraratnaR.A.Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. J Am Acad Dermatol.1998 May; 38(5 Pt 1): 705–11.
22.
Van der KerkhofP.C.M.The effect of addition of calcipotriol ointment (50 ug/g) to acitretin therapy in psoriasis. Br J Dermatol.1998; 138: 84–89.
